# Millennium Pharma

**Canonical:** https://apis.io/providers/millennium-pharma/  
**APIs profiled:** 0

Millennium Pharmaceuticals is a biopharmaceutical company founded in 1993 in Cambridge, Massachusetts, that pioneered a genomics-based, platform approach to drug discovery and development. Backed early on by Mayfield, the company built its reputation on large research and development alliances with major pharmaceutical partners and on discovering and commercializing medicines for cancer and other diseases. Millennium was acquired by Takeda Pharmaceutical Company in 2008 and now operates as the Takeda Oncology unit. It is a therapeutics and drug-discovery organization, not an API or developer-platform provider, and exposes no public developer portal, API documentation, or SDKs.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Pharmaceuticals, Biotechnology, Genomics, Drug Discovery, Oncology, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/millennium-pharma/). Scores are computed from the provider's own public artifacts under a published rubric.